Skip to main content
$57.50 -$1.00 (-1.7%)

04:00 PM EST on 01/27/21

AtriCure, Inc. (NASDAQ:ATRC)

CAPS Rating: No stars

The Company develops, manufactures and sells innovative surgical devices designed to create precise lesions, or scars, in cardiac and soft tissues.

Current Price $57.50 Mkt Cap $2.6B
Open $57.50 P/E Ratio 0.00
Prev. Close $57.50 Div. (Yield) $0.00 (0.0%)
Daily Range $56.57 - $59.89 Volume 510,989
52-Wk Range $23.17 - $59.89 Avg. Daily Vol. 382,319

Caps

How do you think NASDAQ:ATRC will perform against the market?

Add Stock to CAPS Watchlist

All Players

49 Outperform
7 Underperform
 

All-Star Players

13 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ATRC Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

pennysplants (97.09)
Submitted June 29, 2010

Sometimes, you just take a small position in a long shot ... and ride it out. I think AtriCure may have turned the corner. Still a long shot ... but no longer a crap shoot.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

Recent Community Commentary

Read the most recent pitches from players about ATRC.

Recs

0
Member Avatar Turtlebale (43.11) Submitted: 8/26/2016 2:37:46 PM : Outperform Start Price: $14.70 NASDAQ:ATRC Score: +218.23

growing markets

Recs

0
Member Avatar TripleTheMarket (< 20) Submitted: 6/2/2011 1:05:41 PM : Outperform Start Price: $14.45 NASDAQ:ATRC Score: +113.63

Momentum!

Recs

0
Member Avatar dstnewman (96.31) Submitted: 2/23/2008 3:23:31 PM : Outperform Start Price: $11.95 NASDAQ:ATRC Score: +193.28

Strongly considering adding this to my real portfolio when I get a little more cash to invest.

New company just came public back in 2006. The have had consistant growth ever since. One of the biggest attractions that I have to the company is the fact that a large portion of it's income is from procedures that are not officially FDA approved. It is working towards approval, at which point it can start marketing it specifically for that cause. Margins are very good and Y-O-Y growth looks quite interesting. It is still a couple years from being profitable though, which makes it very speculative, but it has multiple FDA trials that are scheduled to be completed this year (08), which means that there are a LOT of catalysts for growth.

Leaderboard

Find the members with the highest scoring picks in ATRC.

Score Leader

Buckless1120

Buckless1120 (< 20) Score: +1,042.90

The Score Leader is the player with the highest score across all their picks in ATRC.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Buckless1120 < 20 11/3/2008 Outperform 1Y $4.00 +1,337.50% +294.60% +1,042.90 0 Comment
invest4321 65.95 8/10/2010 Outperform 5Y $6.80 +745.59% +234.38% +511.20 0 Comment
bashstocks 46.62 3/4/2013 Outperform 1Y $8.50 +576.47% +146.71% +429.76 0 Comment
pkhann1 < 20 2/14/2013 Outperform 1Y $8.54 +573.30% +145.90% +427.40 0 Comment
BeachWeb67 < 20 11/11/2010 Outperform 5Y $8.10 +609.88% +209.30% +400.57 0 Comment
n2camo 43.50 8/14/2013 Outperform 3M $9.39 +512.35% +120.85% +391.50 0 Comment
looktroyson 49.04 6/25/2013 Outperform 5Y $9.25 +521.62% +136.63% +384.99 0 Comment
sonytechrep < 20 12/8/2006 Outperform 3W $9.45 +508.47% +181.64% +326.82 0 Comment
RayCool 80.65 11/28/2006 Outperform 3W $9.50 +505.26% +186.95% +318.31 0 Comment
AlCzervik1980 59.32 6/13/2007 Outperform NS $10.10 +469.31% +161.71% +307.60 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ATRC.